AI filing briefs · archive

8-K filings in February 2026, explained

1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

10 of 1,673 briefs match

newest first · times in ET
PEPPEPSICO INC Feb 2, 6:12 PM ET

PepsiCo Q4 2025 EPS rose 68% to $1.85; full-year EPS fell 14% to $6.00 on impairment

Mixed earnings Written later 2.02

PepsiCo reported fourth-quarter 2025 net revenue of $29.3 billion, up from $27.8 billion a year earlier, and EPS of $1.85 versus $1.11. For the full year, net revenue rose 2.3% to $93.9 billion, but EPS fell to $6.00 from $6.95, mainly due to impairment charges of $1.99 billion, primarily related to the Rockstar brand. The company affirmed its 2026 guidance and raised its annualized dividend 4% to $5.92 per share, while announcing a new buyback of up to $10 billion through February 28, 2030.

  • Q4 2025 net revenue $29,343 million vs. $27,784 million; EPS $1.85 vs. $1.11 (up 68%)
  • Full-year 2025 net revenue $93,925 million vs. $91,854 million (up 2.3%); EPS $6.00 vs. $6.95 (down 14%)
  • Full-year 2025 impairment of intangible assets $1,993 million, primarily related to the Rockstar brand
  • 2026 guidance affirmed: organic revenue growth 2% to 4%, core constant currency EPS growth 4% to 6%; dividend to $5.92 from $5.69 per share, payable June 2026
Read the filing on SEC.gov ↗
ASHASHLAND INC. Feb 2, 5:11 PM ET

Ashland Q1 sales fall 5% to $386 million; EBITDA guidance narrowed to $400-$420 million

Mixed guidance Written later 2.027.01

Ashland reported first-quarter fiscal 2026 sales of $386 million, down 5% from $405 million a year earlier, and Adjusted EBITDA of $58 million, down 5%. The company narrowed its full-year Adjusted EBITDA guidance to $400 million to $420 million from $400 million to $430 million, citing about $11 million of temporary impacts from the Calvert City startup delay and weather disruptions, isolated to the second quarter.

  • Sales $386 million, down 5% from $405 million; Adjusted EBITDA $58 million, down 5% from $61 million
  • Net loss of $12 million, or $(0.26) per diluted share, versus a $165 million loss a year earlier that included the Avoca impairment
  • Fiscal 2026 Adjusted EBITDA guidance narrowed to $400 million to $420 million from $400 million to $430 million
  • Calvert City startup delay and recent weather disruptions cited for approximately $11 million of temporary impacts in the second quarter
Read the filing on SEC.gov ↗
NJRNEW JERSEY RESOURCES CORP Feb 2, 4:31 PM ET

New Jersey Resources raises fiscal 2026 earnings guidance by $0.25 a share; Q1 profit falls

Mixed guidance Written later 2.027.01

New Jersey Resources reported first-quarter fiscal 2026 net income of $122.5 million ($1.22 per share), down from $131.3 million a year earlier, as the prior-year period included a gain on the sale of Clean Energy Ventures' residential solar assets. The company raised its fiscal 2026 net financial earnings per share guidance to $3.28 to $3.43 from $3.03 to $3.18, a $0.25 increase, citing Energy Services performance in January 2026.

  • Q1 net income $122.5 million ($1.22 per share) vs. $131.3 million ($1.32) a year earlier; net financial earnings $118.2 million ($1.17 per share) vs. $128.9 million ($1.29)
  • Fiscal 2026 NFEPS guidance raised to $3.28 to $3.43 from $3.03 to $3.18; long-term 7% to 9% NFEPS growth target maintained
  • Total operating revenues rose to $604.9 million from $488.4 million; Energy Services NFE increased to $16.3 million from $7.8 million
  • Clean Energy Ventures NFE fell to $9.6 million from $48.1 million, mainly due to the November 2024 one-time gain on sale
Read the filing on SEC.gov ↗
DOCHEALTHPEAK PROPERTIES, INC. Feb 2, 4:18 PM ET

Healthpeak reports Q4 2025 net income of $0.16 per share; 2026 EPS guidance $0.34-$0.38

Mixed earnings Written later 2.027.01

Healthpeak reported fourth-quarter 2025 diluted net income of $0.16 per share, up from $0.01 a year earlier, while full-year 2025 net income fell to $0.10 per share from $0.36 in 2024. It set 2026 guidance of $0.34 to $0.38 per share for diluted earnings and $1.70 to $1.74 per share for Nareit FFO, which is below the $1.81 it reported for 2025. The company also plans an initial public offering of Janus Living, a senior housing REIT, expected in the first half of 2026.

  • Q4 2025: net income $0.16 per share vs. $0.01 a year earlier; Nareit FFO $0.47 vs. $0.44; AFFO $0.40 vs. $0.44
  • Full-year 2025: net income $0.10 per share vs. $0.36 in 2024; Nareit FFO $1.81 vs. $1.61
  • 2026 guidance: diluted EPS $0.34 to $0.38; Nareit FFO $1.70 to $1.74 per share
  • Board declared $0.305 per share in dividends for Q1 2026; Janus Living IPO expected in the first half of 2026
Read the filing on SEC.gov ↗
DVADAVITA INC. Feb 2, 4:07 PM ET

DaVita Q4 revenue rises to $3.62 billion; 2026 adjusted EPS guided at $13.60-$15.00

Mixed earnings Written later 2.02

DaVita reported fourth-quarter 2025 revenue of $3.620 billion, up from $3.295 billion a year earlier, while GAAP diluted EPS from continuing operations fell to $2.94 from $3.09 and operating income was $561 million versus $565 million. The company also issued 2026 guidance of $13.60 to $15.00 adjusted diluted EPS, $2.085 billion to $2.235 billion adjusted operating income, and $1.000 billion to $1.250 billion free cash flow, compared with 2025 adjusted diluted EPS of $10.78.

  • Q4 2025 consolidated revenue was $3.620 billion versus $3.295 billion in Q4 2024; operating income was $561 million versus $565 million.
  • Q4 2025 diluted EPS from continuing operations was $2.94 (Q4 2024: $3.09); adjusted diluted EPS was $3.40 (Q3 2025: $2.51).
  • 2026 guidance: adjusted operating income of $2,085 million to $2,235 million and adjusted diluted EPS of $13.60 to $15.00.
  • Repurchased 2.7 million shares for $331 million in Q4 2025, and 1.7 million shares for $200 million from January 1 through February 2, 2026.
Read the filing on SEC.gov ↗
MTGMGIC INVESTMENT CORP Feb 2, 4:04 PM ET

MGIC Q4 2025 net income falls to $169.3 million; EPS rises to $0.75

Mixed earnings Written later 2.02

MGIC Investment Corporation reported fourth-quarter 2025 net income of $169.3 million, or $0.75 per diluted share, compared with $184.7 million, or $0.72 per diluted share, a year earlier. Net income for the full year 2025 was $738.3 million, or $3.14 per diluted share, versus $763.0 million, or $2.89 per diluted share, in 2024, while quarterly losses incurred rose to $31.2 million from $8.7 million.

  • Q4 2025 net income $169.3 million vs. $184.7 million in Q4 2024; diluted EPS $0.75 vs. $0.72
  • Q4 2025 net premiums earned $236.0 million vs. $241.3 million a year earlier; total revenues $298.7 million vs. $301.4 million
  • Q4 2025 losses incurred, net $31.2 million vs. $8.7 million in Q4 2024; loss ratio 13.2% vs. 3.6%
  • January 2026: repurchased 2.7 million shares for $73.2 million and declared a $0.15 per share dividend payable March 6, 2026
Read the filing on SEC.gov ↗
ROCKGIBRALTAR INDUSTRIES, INC. Feb 2, 8:14 AM ET

Gibraltar completes $1.335 billion acquisition of OmniMax International

Mixed m&a Written later 1.011.022.012.037.01

Gibraltar closed its all-cash acquisition of OmniMax International, valued at $1.335 billion and subject to customary adjustments, on February 2, 2026. The deal was funded with new credit facilities, including $1.3 billion in term loans and a $500 million revolver, and the company's prior credit facility was terminated and repaid, so shareholders will see substantially higher debt alongside the company's stated synergy and deleveraging targets.

  • Acquisition closed February 2, 2026 at a value of $1.335 billion, all cash, subject to customary post-closing adjustments
  • New Credit Agreement with Bank of America, N.A. as administrative agent includes $500.0 million revolver, $650.0 million Term Loan A and $650.0 million Term Loan B
  • Management targets $27 million of cost synergies, with $35 million by the end of year three, and deleveraging to 2.0-2.5x within 24 months
  • Credit agreement sets maximum total net leverage of 5.25:1.00, stepping down to 4.25:1.00, and minimum interest coverage of 3.00:1.00
Read the filing on SEC.gov ↗
TSNTYSON FOODS, INC. Feb 2, 7:03 AM ET

Tyson Foods Q1 sales rise 5.1% to $14.3 billion, but GAAP EPS falls to $0.24

Mixed earnings Written later 2.02

Tyson Foods reported first-quarter fiscal 2026 results ended December 27, 2025, with sales up 5.1% to $14.3 billion. Profit fell sharply, with GAAP operating income down 48% to $302 million and GAAP EPS down 76% to $0.24, while adjusted EPS fell 15% to $0.97. The company also gave fiscal 2026 guidance for total adjusted operating income of $2.1 billion to $2.3 billion and sales growth of 2% to 4%.

  • Sales of $14,313 million, up 5.1%; excluding a $150 million increase in legal contingency accruals recorded as a reduction to sales, sales rose 6.2%
  • GAAP operating income of $302 million, down 48%; adjusted operating income of $572 million, down 13%
  • Adjusted EPS of $0.97, down 15% from $1.14; beef segment adjusted operating loss of $143 million
  • Fiscal 2026 outlook: total adjusted operating income of $2.1 billion to $2.3 billion, free cash flow of $1.1 billion to $1.7 billion
Read the filing on SEC.gov ↗
APTVAptiv PLC Feb 2, 6:49 AM ET

Aptiv Q4 revenue rises 5% to $5.2 billion; GAAP profit falls to $138 million

Mixed earnings Written later 2.02

Aptiv reported fourth-quarter and full-year 2025 results on February 2, 2026. Revenue rose, but U.S. GAAP net income fell sharply, and full-year GAAP results include a $648 million non-cash goodwill impairment, while adjusted earnings per share rose. The company also issued 2026 guidance ahead of its planned spin-off of the Electrical Distribution Systems business as Versigent.

  • Q4 2025 revenue was $5.2 billion, up 5%; U.S. GAAP net income was $138 million, versus $268 million a year earlier.
  • Q4 diluted EPS was $0.64 on a U.S. GAAP basis versus $1.14 a year earlier; adjusted EPS was $1.86 versus $1.75.
  • Full-year 2025 U.S. GAAP net income was $165 million, including a $648 million goodwill impairment; adjusted EPS was $7.82 versus $6.26.
  • 2026 guidance calls for net sales of $21.12 billion to $21.82 billion and adjusted EPS of $8.15 to $8.75.
Read the filing on SEC.gov ↗
DISWalt Disney Co Feb 2, 6:42 AM ET

Disney Q1 revenue rises 5% to $26.0 billion, but EPS falls to $1.34

Mixed earnings Written later 2.02

Disney reported fiscal first-quarter revenue of $26.0 billion, up 5% from a year earlier, while diluted EPS fell 4% to $1.34 and adjusted EPS fell 7% to $1.63. Total segment operating income dropped 9% to $4.6 billion, and the company cited a $110 million impact from the temporary suspension of YouTube TV carriage. Disney expects double-digit adjusted EPS growth for fiscal 2026 and is on track to repurchase $7 billion of stock.

  • Revenue rose 5% to $26.0 billion; Experiences reported record quarterly revenue of $10.0 billion
  • Adjusted EPS fell to $1.63 from $1.76; total segment operating income fell 9% to $4.6 billion
  • Fiscal 2026 outlook: double-digit adjusted EPS growth, $19 billion in cash from operations, and $7 billion in planned stock repurchases
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.